QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
Log in
TSE:MBX

Microbix Biosystems Stock Forecast, Price & News

C$0.61
-0.02 (-3.17 %)
(As of 03/1/2021 12:00 AM ET)
Add
Compare
Today's Range
C$0.59
Now: C$0.61
C$0.62
50-Day Range
C$0.41
MA: C$0.52
C$0.64
52-Week Range
C$0.17
Now: C$0.61
C$0.66
Volume107,866 shs
Average Volume222,234 shs
Market CapitalizationC$66.76 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. The company produces infectious disease antigens, including viral, bacterial, and parasitic products, which are used in various applications, such as immunodiagnostic assays comprising ELISA, chemiluminescent automated immunoassays, immunohistochemistry, immunofluorescence, latex agglutination, rapid tests, and flow cytometry. Its infectious disease antigens also used in controls for diagnostic assays, basic and applied research in virology, microbiology, cell biology, immunology, and pathology, or for vaccine and antiviral research and development. The company also provides quality assessment products, including PROCEEDx Verification/Validation samples, which are research use only products for use in test system IQ/OQ/PQ, verification/validation, and training; PTDx proficiency testing products; and REDx Controls, which are designed to enhance the diagnostic quality outcome by early detection of the deviations from desired assay performance. In addition, it develops Kinlytic Urokinase for injection, a thrombolytic biologic drug used to treat blood clots; and LumiSort cell-sorting, a technology for sorting of particles that could be used to enrich cell populations of interest, such as in sexing semen. The company also offers viral transport media that stabilize the organisms in patient samples. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-905-3618910
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$11.64 million
Cash FlowC$0.00 per share
Book ValueC$0.06 per share

Profitability

Miscellaneous

Market CapC$66.76 million
Next Earnings Date5/13/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

0.87 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
C$0.61
-0.02 (-3.17 %)
(As of 03/1/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MBX News and Ratings via Email

Sign-up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Microbix Biosystems (TSE:MBX) Frequently Asked Questions

What stocks does MarketBeat like better than Microbix Biosystems?

Wall Street analysts have given Microbix Biosystems a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Microbix Biosystems wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Microbix Biosystems' next earnings date?

Microbix Biosystems is scheduled to release its next quarterly earnings announcement on Thursday, May 13th 2021.
View our earnings forecast for Microbix Biosystems
.

How were Microbix Biosystems' earnings last quarter?

Microbix Biosystems Inc. (TSE:MBX) released its earnings results on Friday, December, 18th. The company reported ($0.05) earnings per share for the quarter. The firm earned $2.71 million during the quarter.
View Microbix Biosystems' earnings history
.

How has Microbix Biosystems' stock price been impacted by COVID-19 (Coronavirus)?

Microbix Biosystems' stock was trading at C$0.22 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MBX stock has increased by 177.3% and is now trading at C$0.61.
View which stocks have been most impacted by COVID-19
.

Who are Microbix Biosystems' key executives?

Microbix Biosystems' management team includes the following people:
  • Mr. Cameron L. Groome, Pres, CEO & Director
  • Mr. James S. Currie, Chief Financial Officer
  • Dr. Kenneth Hughes Ph.D., Chief Operating Officer
  • Mr. Philip Casselli, Sr. VP of Sales, Bus. Devel. & Marketing
  • Dr. Mark Luscher Ph.D., Sr. VP of Scientific Affairs
  • Mr. Christopher B. Lobb, Compliance Officer, Gen. Counsel & Sec.

Who are some of Microbix Biosystems' key competitors?

What other stocks do shareholders of Microbix Biosystems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Microbix Biosystems investors own include TransAlta Renewables (RNW), (CGC), OrganiGram Holdings Inc. (OGI.TO) (OGI), Dynavax Technologies (DVAX), Heat Biologics (HTBX), VEON (VEON), Vaxart (VXRT), Wajax (WJX), BlackBerry (BB) and Canadian Western Bank (CWB).

What is Microbix Biosystems' stock symbol?

Microbix Biosystems trades on the Toronto Stock Exchange (TSX) under the ticker symbol "MBX."

How do I buy shares of Microbix Biosystems?

Shares of MBX and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Microbix Biosystems' stock price today?

One share of MBX stock can currently be purchased for approximately C$0.61.

How much money does Microbix Biosystems make?

Microbix Biosystems has a market capitalization of C$66.76 million and generates C$11.64 million in revenue each year.

What is Microbix Biosystems' official website?

The official website for Microbix Biosystems is microbix.com.

Where are Microbix Biosystems' headquarters?

Microbix Biosystems is headquartered at 265 Watline Ave, MISSISSAUGA, ON L4Z 1P3, Canada.

How can I contact Microbix Biosystems?

Microbix Biosystems' mailing address is 265 Watline Ave, MISSISSAUGA, ON L4Z 1P3, Canada. The company can be reached via phone at +1-905-3618910.


This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.